Viral infections in humans are frequently associated with granulocytopenia and/or granulocytosis. Such changes in myelopoiesis could result from infection of the granulocyte-macrophage colony-forming cell (CFC-GM) or changes in the production of colony-stimulating activity (CSA). Endothelial cells are a known source of CSA and may be transiently or persistently infected during a number of viral infections, including infection with herpes simplex virus type I (HSV-I) and measles virus. Therefore, we examined the effect of
Introduction
Growth of myeloid progenitors within the bone marrow is believed to depend on a series of glycoproteins collectively known as colony-stimulating factors (1) . A variety of normal cells and malignant cell lines grown in tissue culture (2) (3) (4) (5) have been shown to secrete proteins that have colony-stimulating activity (CSA).' The ability of CSA to promote myelopoiesis in vitro can be inhibited by the addition of acidic isoferritins, lactoferrin, prostaglandin El, and certain types ofinterferon (6) (7) (8) (9) . However, far less is known about the relative importance of the actual level of CSA or the relative roles of each of these inhibitors of colony formation in clinical disorders of granulopoiesis.
For example, viral infections are frequently associated with the development ofgranulocytosis and/or granulocytopenia (10) (11) (12) (13) , but the mechanisms by which these occur have received little study. Lymphocytes with the T helper phenotype, which are the most prevalent subset of T cells in healthy normal individuals, have been shown to be an important source of CSA (3, 14) . Infection with Epstein-Barr virus (EBV) and cytomegalovirus (CMV) may be accompanied by the development of neutropenia (15) (16) (17) . Both of these viruses induce the proliferation of T suppressor cells (I15-17), which may inhibit the growth of granulocyte-macrophage colony-forming cells (CFC-GM) (18) and may produce less CSA than the normal T helper cells. Either event might lead to the development of neutropenia.
Other mechanisms by which neutropenia might develop are also possible. Several viruses, such as parvoviruses, are capable of replicating within marrow progenitor cells (1 1, 19) . The responsiveness ofbone marrow cells to either CSA or its inhibitors could be directly affected by the presence of virus. Retroviruses and other viruses are also capable ofdirectly modifying the synthesis or release of CSA by certain infected cells (20) .
We have previously shown that several common human viruses are capable of infecting and replicating within human endothelial cells, a known source of CSA (21) (22) (23) . We therefore studied whether infection of endothelial cells with certain of these viruses would alter their production of CSA.
Methods
Endothelial cell culture Primary cultures of human umbilical venous endothelial cells were established as previously described (23) (24) (25) (26) (27) (28) and passaged by a 3-5-min exposure to I% trypsin/EDTA (Gibco Laboratories, Grand Island, NY) (26) . Over 95% of the cells in the monolayer were Factor VIII antigen positive (23, 26) . Nonspecific esterase (NSE), compatible with the presence of monocytes, was found on <5% of the cells in primary cultures and was not detected in subsequent passages.
Viral infection ofendothelial cells 24 h after passage, endothelial cells were infected with either herpes simplex virus type I (HSV-I) or the Edmonston vaccine strain of measles virus as previously described (22) . Briefly, the medium was removed from the monolayers and the cells were incubated with HSV-I, at a activity; EBV, Epstein-Barr virus; Endo-CM, endothelial cell-conditioned medium; HSV-I, herpes simplex virus type I; MCM, monocyte-conditioned medium; MRA, monocyte-derived recruiting activity; NSE, nonspecific esterase; PDB, phorbol 12,13-dibutyrate; PHA, phytohemagglutinin; PHA-LCM, PHA lymphocyte-conditioned medium. multiplicity of input (MOI) of one infectious virus per cell (1.0 X 105 tissue culture infectious doses of virus/well), or with measles virus at an MOI of 0.3. The virus was allowed to adsorb to the cell for 1 h at 370C, the monolayer was washed, and control or modified medium containing 10% fetal calf serum (FCS) was added. In each experiment, replicate cultures were sham-infected with the vehicle or medium in which the virus was prepared.
To determine whether measles virus must replicate within the endothelial cells for CSA to be produced, experiments were performed in parallel with endothelial cells exposed to UV-inactivated virus, which we prepared as previously described (21) . This exposure of measles virus to UV light reduced the titer of infectious virus from 3 X 101 virions/ ml to 0.
Since the amount ofCSA in our experiments was determined by the growth of human bone marrow cells (see below), the presence of live virus in the supernatants of measles or HSV-I-infected endothelial cells could alter the amount of CSA we subsequently detected. Similarly, the presence of residual live virus could affect the measurement ofinterferon activity (see below). Therefore, any potential live virus was removed from replicate culture supernatants in these experiments by two methods. First, live virus potentially present in the culture supernatants was inactivated with UV light as above. Then, intact (inactivated) viral particles were removed by ultracentrifugation at 100,000 g for 18 h at 40C before their addition to the human bone marrow cells (for CSA determinations) or fibroblasts (for determination of interferon) (see below). All titrations oflive measles virus and HSV-I were performed in MRC-5 strain human embryonic lung fibroblasts (22) .
Preparation ofconditioned medium
Monocyte-conditioned medium (MCM). MCM was prepared by a modification of the method of Bagby et al. (29, 30) as previously described (31) . Briefly, a low density mononuclear cell population was prepared from whole blood by Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) gradient centrifugation and resuspended in RPMI culture medium (Gibco Laboratories) at 2 X 106 cells/ml. The cells were allowed to adhere to FCS-pretreated 75-cm2 tissue culture flasks (Costar Data Packaging Corp., Cambridge, MA) for 90-120 min (30 ml/flask) (7) . The nonadherent cells were removed by aspiration and the adherent monolayer was washed twice with RPMI 1640 culture medium (Gibco). Over 90% of the adherent cells showed positive staining for NSE and were therefore considered to be monocytes (31). 1-3 X I05 cells/ml were then placed in 20 ml of RPMI 1640 containing 10% FCS for 5 d at 370C
in an atmosphere of 5% CO2, at which time the culture medium was centrifuged at 500 g for 10 min and filtered through a Nalgene 0.45-Mm filter (Sybron Corp., Rochester, NY). This MCM was stored at either 40C for up to 1 mo or at -20'C for up to 2 mo before use as a supplement for the endothelial cell cultures. We found that preparations of MCM we had stored at 40C retained a greater ability to induce CSA than samples that had been frozen and thawed.
Endothelial cell-conditioned medium (Endo-CM). Supernatantsfrom endothelial cell cultures, which we have designated Endo-CM, were prepared by centrifuging the cell culture at 500 g for 10 min. Endo-CM was stored at -20°C for up to 6 mo without loss of CSA. Endo-CM was harvested from the endothelial cells prepared using several different culture conditions: (a) primary cultures of endothelial cells without additional stimulation were studied from the time the cells were initially placed in culture (time zero) and daily thereafter for 1 wk; (b) endothelial cell monolayers were prepared after a single passage and similarly studied over the first week without additional stimulation; (c) passaged endothelial cells were incubated with 0 or 25% MCM for 0-8 d before removing the Endo-CM; (d) passaged endothelial cells were infected with live or UVinactivated measles virus or HSV-I, or were sham-infected as detailed above. One half of the endothelial cell cultures were then incubated in complete medium alone while the other halfwere incubated in complete medium supplemented with 25% MCM.
We also performed a series of experiments to determine whether the 
Role of interferon
We also determined whether the virally infected endothelial cells or cells stimulated with MCM secreted a-, (3-, or 'y-interferon into the Endo-CM. The total amount of interferon in the endothelial cell cultures was determined by assaying the extent of inhibition of the cytopathic effect of vesicular stomatitis virus on both bovine (EbTr strain) and human (Detroit 539 strain) fibroblasts, by established techniques (kindly performed by Dr. Bice Perussia, Wistar Institute, Philadelphia, PA) (32) . Antiviral units are expressed as the reciprocal of the dilution inhibiting 50% of the cytopathic effect and are equivalent to one reference unit of the National Institutes of Health (NIH) human (a, -y) reference interferon (IFN G-023-901-527).
The molecular species of interferon synthesized by the endothelial cells was then determined. Each sample containing interferon activity was incubated with an excess ofa polyclonal anti-a-interferon or a polyclonal anti-(3-interferon antibody (101 neutralizing U/ml) (Interferon Sciences, ICN Pharmaceuticals, Inc., Irvine, CA) or with a murine monoclonal anti-y-interferon antibody (provided by Drs. Bice Perussia and Giorgio Trinchieri, Wistar Institute, Philadelphia, PA, and containing 3.3 X 104 neutralizing U/ml) before addition to the fibroblast monolayer. Residual interferon activity was then determined at 18 and 48 h. The amount of y-interferon secreted into the endothelial cell supernatants was also determined by radioimmunoassay (kindly performed by Dr. Trinchieri). Briefly, a monoclonal anti-y-interferon antibody (33) was linked to cyanogen bromide-activated Sepharose 4B; the antibody-coated beads were then incubated with purified NIH 'y-interferon or the endothelial cell supernatants for 3 h at 22°C and 1 h at 4°C. The beads were then washed and incubated with a second '25I-labeled murine IgG anti-y-interferon antibody. After three additional washes, the beads were counted for bound radioactivity in a gamma scintillation counter. Purified NIH y-interferon (5,000 U) was used as the positive control in the experiments; conditioned medium from two PHA (0.3%) -stimulated normal human mononuclear cell preparations contained a mean of 12,600 U of activity.
Experiments were also performed to determine whether small amounts of interferon, which were below our ability to detect or which were active within the cell, could play a role in CSA production. Endothelial cells were preincubated with either partially purified a-interferon (Leucoferon; Biotechnologies, Inc., Hartford, CT) (1-1,000 U/ I0O cells), identical concentrations of recombinant y-interferon (Genentech Inc., San Francisco, CA), or y-interferon from stimulated human lymphocytes (Ventrex Laboratories, Portland, MA) in the presence or absence of MCM for 72 h. The cells were then washed and incubated with media containing MCM, MCM plus interferon, or control media for an additional 72 h before assay.
CFC-GM assay
The quantity of CSA present in conditioned culture medium (MCM and Endo-CM) was established using a bioassay ofCFC-GM as previously described (31) . Briefly, mononuclear cells were isolated from human bone marrow by Ficoll-Hypaque density gradient centrifugation and allowed to adhere to culture flasks that had been preincubated overnight in normal human serum, for 1 h at 370C in 10% CO2. The nonadherent cells were then removed and used to measure CSA in single-layer agar cultures by a modification ofthe method of Metcalfet al. (5) as previously described (31, 34) . To perform this assay, marrow cells at 2 X 106 cells/ ml were diluted 1:20 with an equal mixture of double-strength supplemented Dulbecco's modified Eagle's medium and 0.6% Bacto agar (Difco Laboratories Inc., Detroit, MI) maintained between 37 and 40'C. Each source of conditioned medium was placed in a culture dish at 10% final volume. The mixture of nonadherent bone marrow cells in agar was added and allowed to cool to a gel at 220C for 20 min before incubation for 14 d at 370C in a fully humidified incubator in an atmosphere of 10% CO2. Duplicate or triplicate agar cultures were counted at a magnification of40 (American Optical Corp., Buffalo, NY) to determine the number ofclusters ( 10-49 cells) and colonies (>50 cells) that developed. Results are presented as the mean±SEM for multiple experiments, using the average combined number ofclusters and colonies per I05 low density nonadherent marrow cells from each experiment. This mean is referred to as colonies. The standard deviation of triplicate samples was <10% ofthe mean value in an individual experiment. Conditioned media from PHA-stimulated leukocytes (PHA-LCM) were prepared as previously described (31, 34) and used as a known source of CSA.
In certain experiments, the colony cell type was delineated by evaluating each colony for the presence of NSE, a monocyte marker, and chloroacetate esterase, a granulocyte marker (31) . Colonies in which >90% of the cells were of one esterase type were scored as staining for that cell type; otherwise they were scored as mixed.
Preparation ofendothelial cell cytosol
We wanted to know whether the presence of CSA in the endothelial cell supernatants reflected only ongoing synthesis or whether additional CSA was stored within the cell and released after cell lysis. Therefore, we determined the amount of CSA that could be released from endothelial cell cytoplasm after mechanical disruption. To perform this experiment, we prepared endothelial cell cytosol from -8 X 106 cells per sample. Stimulated, infected, or control cultures ofendothelial cells were washed and resuspended in Medium 199. The protease inhibitors phenylmethylsulfonyl fluoride (17.4 mg/ml), L-glutamyl-L-tyrosine (44.4 mg/ml in ethanol), and benzamidine hydrochloride (1.52 mg/ml) were added. The intact cells were fractured by nitrogen cavitation by exposure to 1,200-1,500 psi for 15 min (Parr Instrument Co., Moline, IL). Large membrane pellets were removed by centrifugation at 10,000 g for 10 min (model L5-50; Beckman Instruments, Inc., Fullerton, CA) The supernatants were then spun at 100,000 g for 30 min and assayed at a 10%6 final volume for CSA.
Results

CSA release by primary cultures ofendothelial cells
We first determined whether primary cultures of uninfected and unstimulated human umbilical venous endothelial cells released detectable CSA. We found that conditioned medium harvested from primary endothelial cell cultures at 48 h contained large amounts ofCSA (Fig. 1) . However, when the cells were incubated for an additional 2-5 d, progressively less CSA was released into the medium, and after the fourth day ofculture, little additional CSA was released. A number of agents were then added to day 4 (Fig. 3) . As we observed with primary cultures, passaged endothelial cells did not secrete CSA after the addition of PDB or PHA. Therefore, the effect of MCM was not due to manipulation of the cell culture itself. We then sought to determine whether unstimulated or MCM-stimulated endothelial cells stored large amounts of CSA within their cytosol. To perform this experiment, we determined the amount of CSA in the cytosol of unstimulated and MCMstimulated endothelial cells after cell lysis. We found no detectable CSA in either cytosol preparation (Fig. 2) . These data suggested to us that MCM induces both the synthesis and prompt release of most CSA produced by endothelial cells, although we cannot exclude the possibility that some CSA remains associated with the internal membrane fraction or that inhibitors of CSA may be present as well. The results further suggested that the presence of CSA in Endo-CM did not reflect nonspecific release ofglycoproteins that had accumulated within the cell at an earlier time and that were then released after cell lysis or death.
CSA release by endothelial cells infected with HSV-I
We chose to study endothelial cell production of CSA after infection with two viruses that have differing effects on these cells in vitro. Under the conditions of these experiments, HSV-I produces a rapidly progressive infection of the endothelium, with evidence of cell rounding and detachment by 24 -72 h after infection. Therefore, this virus was chosen to determine the effect of cell injury and disruption on CSA release. In contrast, measles infection does not produce early endothelial disruption. Viral replication occurs between 48 and 96 h after infection, the release of viral particles first being detectable at 72 h. The cells begin to produce syncytia, with the loss of distinct cell contours by day 4. Infected cells continue to release viral particles for up to 10 d, with only a gradual loss of cell attachment and viability (22) .
Passaged endothelial cells were exposed to HSV-I for 1 h, washed, and then incubated with control culture medium or medium supplemented with 25% MCM to stimulate CSA production. Cultures ofendothelial cells that had been sham-infected with fresh media alone and then exposed to MCM showed the expected production of CSA within 24 h (Fig. 5) (Fig. 7) . In contrast, measles-infected endothelial cells produced their maximal amount of CSA within the first 24 h, a lesser amount of CSA between days 1-3, and no additional CSA thereafter. However, these measles-infected cells retained the capacity to produce CSA in response to MCM for up to 6 d in culture.
We next asked whether the presence of live measles virus in the endothelial cell supernatants altered the apparent level of CSA we observed, by infecting and directly stimulating target cells within the bone marrow cell assay system. To test this possibility, any live virus potentially present in the endothelial cell supernatants was inactivated with UV light, viral particles were removed by ultracentrifugation, and the Endo-CM was reassayed for CSA activity. No live measles could be detected in these UVinactivated endothelial cell culture supernatants when they were added to a permissive cell line in which viral growth produces visible pathologic changes (22) . Nevertheless, the amount of CSA present in the supernatants of measles-infected endothelial cells We found that neither unstimulated nor MCM-stimulated passaged endothelial cells secreted interferon active on bovine or human fibroblasts (Fig. 8 A) . In addition, the supernatants of endothelial cells that had been infected with HSV-I for 6, 24, or 48 h also contained little (.2 U) interferon (Fig. 8 A) .
In contrast, supernatants of measles-infected endothelial cells contained interferon beginning 24 h postinfection, which reached a maximum at 5 d (Fig. 8 A) . Interferon secreted by the measlesinfected cells was active on human, but not bovine fibroblasts, which suggest that endothelial cells secrete either fl-or 'y-interferon (32) . The addition of an anti-y-interferon or an anti-ainterferon antibody capable of neutralizing 20,000 U of interferon activity had no effect on the titer of interferon present in the supernatants of the measles-infected endothelial cells ( shown). In contrast, addition of anti-c-interferon antibody totally eliminated detectable interferon activity in the endothelial cell supernatants (Fig. 8 B) . Endothelial cells infected with UVinactivated HSV-I or measles did not secrete interferon. Therefore, it did not appear likely that the opposing effects of HSV-I and measles on the secretion of CSA by endothelial cells could be explained by the level of interferon secreted into the media. In addition, no interferon was detected in the MCM-stimulated cells, which indicates that its presence is not required to mediate CSA production by endothelial cells. We next addressed the possibility that either a-or -y-interferon could immediately be taken up by surface receptors or could be acting within the cell and therefore be undetectable in the conditioned media. Endothelial cells incubated with 10-1,000 U of a-or y-interferon secreted the same amount ofCSA as control cultures (Fig. 9) . The addition of a-or y-interferon ulated with MCM alone only at the highest interferon levels tested. Inhibition of CSA required amounts of interferon that would be >100-fold higher than those that could potentially be present in the supernatants of the virally infected endothelial cells and yet remain undetectable in our assay systems. In no case did the presence of interferon suppress the production of CSA to the levels seen after infection of endothelial cells with HSV-I (Figs. 8 and 9 ).
Production ofother inhibitors ofCSA by endothelial cells
We next sought to determine whether endothelial cells incubated with MCM or infected with either virus produced any inhibitor(s) ofCSA activity in addition to interferon. To investigate whether such an inhibitor was present, we mixed conditioned medium, obtained between days 3 and 8, from uninfected or virally infected primary cultures or passaged endothelial cells, with PHA-LCM, a standard source of CSA, and the resultant number of CFC-GM was determined. Neither unstimulated, MCM-stimulated, nor HSV-I-infected endothelial cells produced any inhibitor that was biologically active in our assay system. Furthermore, no inhibitor was detected in supernatants of endothelial cell cultures infected with measles virus for up to 8 d.
Distribution ofcolony types induced by endothelial cell CSA
We compared the distribution of colony cell types induced by CSA obtained from uninfected passaged endothelial cells stimulated with MCM (day 3) with the type of colonies induced by CSA prepared from PHA-stimulated lymphocytes (Fig. 10) . Whereas PHA-LCM induced the formation of approximately equal numbers of granulocyte and macrophage colonies, endothelial cell CSA induced predominantly (75%) granulocyte colonies. We observed this same predominance of granulocyte colonies when we studied endothelial cell CSA induced by measles infection (Fig. 10 ).
Discussion
Profound changes in hematopoiesis may accompany certain human viral infections. fluenza virus, or parvovirus (10, 11, 19, 36) . A period of granulocytopenia frequently develops after infection with EBV or CMV (15) (16) (17) . On the other hand, mild leukocytosis followed by mild leukpenia often follows both natural infection with measles virus and the administration of measles vaccine (37) . Nevertheless, despite the frequent fluctuations of granulocyte counts that develop during viral infection, there has been little systematic study of the mechanisms by which this might occur. Viral infection could effect hematopoiesis in a variety ofways. For example, parvovirus can infect and inhibit the development of erythroid colonies (BFU-E) in vitro, and clinical infection with the virus has recently been implicated in the development of aplastic crises in humans (1 1, 20) . Similarly, infection of erythroid and myeloid precursors with hepatitis B virus may play a role in the aplastic crises that occasionally follow such infections (38) . Similar infection ofbone marrow progenitor cells may occur after CMV infection (39) . Granulocytopenia may also result from the induction of suppressor T cells such as those that develop during EBV and CMV infection (I15-18, 39, 40). Furthermore, a variety of cells produce a-, p3-, and y-interferon after viral infection, and these molecules are known to have an inhibitory effect on myeloid (CFC-GM) colony formation in vitro (9, 41, 42) . Alternatively, several mechanisms have been described by which an expansion of the leukocyte pool may occur after viral infection. For example, infection of murine CFC-GM with the Friend virus complex leads to the loss of normal growth regulation by acidic isoferritin and lactoferrin (43) . Furthermore, certain retroviruses have been shown to directly enhance the release of CSA by murine fibroblasts (20) .
We therefore studied the possibility that viral infection of human endothelial cells might alter their production of CSA. Endothelial cells are a component of the normal bone marrow stroma (44) that can be readily infected by certain viruses in vitro and in vivo (21, 22) and have been shown by other investigators to produce CSA in culture (29, 45, 46) . There are conflicting data as to whether unstimulated endothelial cells produce significant amounts of CSA (29, 45) . In agreement with Bagby et al. (29) , we found that unstimulated passaged human endothelial cells derived from the umbilical vein produce little, if any, biologically active CSA. However, endothelial cells will produce CSA when stimulated by a low molecular weight heatlabile glycoprotein produced and secreted by normal monocytes, which has been called MRA and which is found in MCM (29) . We have shown that the induction of CSA release from endothelial cells requires the continued presence of MCM (Fig. 3) and active protein synthesis by the endothelial cell, and that little additional CSA remains stored within the endothelial cell cytosol (Fig. 3) . It is possible that the presence of CSA found in the supernatants of primary cultures of endothelial cells reflects stimulation in vivo by products of monocytes present in the fetal circulation.
The production of CSA by endothelial cells was also altered by certain viral infections. Infection with HSV-I totally prevented the production of CSA by endothelial cells stimulated by MCM. Total inhibition occurred within 4 h of infection, before the appearance of cytopathic changes, cell lysis, or production of intact virus particles (22) . This inhibition ofCSA synthesis occurs at a time when HSV-I is known to inhibit the synthesis of many host proteins (47, 48) . We investigated the possibility that live herpes virus was present in supernatants ofsome ofthese cultures. Such residual virus could have infected the hematopoeitic stem cells and directly inhibited colony growth in vitro. However, CSA production remained undetectable even after any potential live virus was removed from the Endo-CM by UV inactivation and ultracentrifugation. Furthermore, we found no functional inhibitor of CFC-GM colony formation when these supernatants were mixed with a known amount of CSA and added to the human marrow cell culture. This finding argues against any effect of residual live virus on the measurements of CSA we made. Therefore, it is more likely that herpes simplex directly inhibits the ability of MCM to induce CSA production by endothelial cells. This could be brought about in two ways. Firstly, the lack of CSA production could be part of the general effect of HSV-I to inhibit synthesis of certain cell-specific proteins (47, 48) . Secondly, the failure to respond to MCM could reflect loss of a receptor for MRA or a specific inhibition by the virus of an intracellular event necessary for CSA production or secretion.
In contrast to the results of infection with HSV-I, endothelial cells infected with measles virus were stimulated to produce CSA for the first 24-72 h after infection in the absence of MCM. Furthermore, measles-infected cells remained responsive to MCM for 6 d in culture, well after measles-induced syncytia begin to form (22) . The mechanism by which measles virus stimulates endothelial cells to produce CSA is unknown. The measurement of CSA in the supernatants ofthe measles-infected endothelial cells was not due to the presence oflive virus capable of directly infecting the bone marrow target cells. After UV inactivation and ultracentrifugation of the Endo-CM, no live measles virus was detected in a permissive cell line, although the level of CSA in the Endo-CM was unaffected. Nor was the presence of CSA in the supernatants of measles-infected endothelial cells due to a toxic or lytic effect of the virus on the cells. Endothelial cells appear to store little functionally active CSA, at least free within the cytosol. Active protein synthesis is required for the appearance ofCSA in the culture medium, and infection with HSV-I, which is capable of lysing endothelial cells, produces the opposite effect. Therefore, the appearance ofCSA after measles infection probably involves stimulation of the synthesis of this glycoprotein within the infected endothelial cells.
In all ofour studies, we used nonadherent human bone marrow cells as targets to determine the amount of CSA in our endothelial cell supernatants. This nonadherent cell fraction is heterogeneous and includes various potential accessory cell populations, such as lymphocytes and fibroblasts, in addition to hematopoietic stem cells. Therefore, the conditioned medium secreted by the MRA-stimulated or the measles-infected endothelial cells could contain factors that promote CFCGGM development indirectly, through one or more of these accessory cell populations (31) . Assays using purified human bone marrow stem cells would be required to determine unequivocally the production of CSA itself by endothelial cells.
We studied the role of interferon in the production of CSA that we observed. We first asked ifthe failure of HSV-I-infected endothelial cells to produce CSA, even following stimulation with MCM, could be due to the presence of a-, p3-, or a-interferon in these cell supernatants, since it is known that these molecules can inhibit the development of CFC-GM in the marrow system we employed (9, 41, 42) . However, we found that f3-interferon was produced during measles virus but not HSV-I infection of endothelial cells. Indeed, the supernatants of endothelial cells infected with measles virus contained both p3-interferon as well as functioning CSA. Therefore, based on the known inhibitory effects of interferon on hematopoiesis, the opposite effects of these two viruses on CSA production by endothelial cells cannot be explained solely by their effect on the amount or type of interferon they induce endothelial cells to secrete.
We then considered the possibility that the production of CSA by measles-infected or MCM-stimulated endothelial cells could be mediated, in part, by the synthesis of an interferon molecule having MRA-like activity. Recently (49), endothelial cells have been reported to produce small amounts of CSA-like activity after incubation with gamma interferon, although the number of colonies that could be induced to develop could not account for the magnitude of the results we observed. However, we did not detect y-interferon in the supernatants of the MCMstimulated or measles-infected endothelial cells. It is possible that these cultures might have contained small amounts of aor y-interferon, which were below our ability to detect, or which immediately bound to endothelial cell receptors, or which acted within the cells to cause CSA production. However, we found that the addition of relatively small or relatively large amounts of a-or fy-interferon to endothelial cell cultures, in the absence of MCM, did not initiate production of CSA, excluding a direct MRA-like activity for these molecules, at least under the experimental conditions and using the assay system we employed.
We did not directly study the effect of purified (3-interferon, a known inhibitor of CFC-GM development, on the production of CSA by endothelial cells. Therefore, we cannot exclude the possibility that ,3-interferon plays a role in the production of CSA by measles-infected endothelial cells or the possibility that a lack of f-interferon production by HSV-I-infected cells accounts for the absence ofCSA production induced by this virus. We also did not study the effect on CSA production of adding either interferon or anti-interferon antibodies to virally infected endothelial cells. Therefore, our experiments also do not exclude the possibility that interferon participates in the overall regulation of CSA production under some circumstances. Certainly, the secretion of interferon by virally infected stromal cells would be expected to effect the response of the bone marrow target cells to CSA and other regulatory molecules. Moreover, interferon may only stimulate endothelial cells to produce CSA after the addition of other biologically active molecules (50). However, the absence of significant amounts of interferon in the supernatants of MCM-stimulated cells does suggest that secretion of interferon into the Endo-CM is not required for CSA production, at least when stimulated in this way.
It is also far from certain whether the changes in granulocyte count that occur during viral infection in vivo actually result from the type of changes in the levels of CSA we observed in this study. Viral infections could either alter monocyte production of MRA, change the levels of prostaglandin E2, acidic isoferritins, lactoferrin, or local concentrations ofinterferon within the marrow, or lead to the production of inhibitors of MRA itself. Furthermore, certain viruses may directly alter the responsiveness of bone marrow cells at various stages of differentiation to these regulatory signals. However, it is also possible that transient or persistent changes in CSA production by endothelial cells or other components of the bone marrow stroma may, in fact, play a role in certain clinically important disorders of myelopoiesis.
